Related Experiment Videos
An assay to measure antibiotic efficacy against Staphylococcus epidermidis biofilms on implant surfaces
G K Richards1, R F Gagnon, R J Morcos
1Department of Laboratories, South Saskatchewan Hospital Center, Regina, Canada.
Abstract:
Infection is a major limitation of implantable devices. Optimal antibiotic therapeutic regimes have not yet been defined. Implant-associated infections have a number of differentiating characteristics, which include the predominance of Staphylococcus epidermidis and other skin bacteria of normally low pathogenicity as the causative agents, together with a relative resistance to host defenses and to antibiotic therapy. These properties have been ascribed to the ability of the bacteria to exist on implant surfaces in the biofilm phase, which is protective. An assay of antibiotic activity using a standardized bacterial biofilm preparation of S. epidermidis is described. The assay is used to evaluate the relative efficacy of antibiotics to sterilize the biofilm, when they are used singly, or in double or triple combinations. The modulating effects of changing antibiotic concentrations and modifying the environment with CAPD variables (fresh and spent dialysis fluid, common PD solution additives) are also measured and the data summarized. It is hoped that, by using this and similar assays, individualized optimal therapeutic regimes of implant-associated infections may be logically planned.
Insights
This study developed a new assay to test antibiotic effectiveness against Staphylococcus epidermidis biofilms, crucial for preventing implant infections. The findings aim to guide personalized antibiotic treatments for implant-associated infections.
Area of Science:
- Biomedical Engineering
- Infectious Diseases
- Microbiology
Background:
- Implantable device infections are a significant clinical challenge.
- Implant-associated infections are often caused by Staphylococcus epidermidis biofilms, showing resistance to antibiotics.
- Current antibiotic regimens for these infections are not optimized.
Purpose of the Study:
- To describe a novel assay for evaluating antibiotic efficacy against Staphylococcus epidermidis biofilms.
- To assess the effectiveness of single, double, and triple antibiotic combinations in sterilizing biofilms.
- To investigate the influence of varying antibiotic concentrations and continuous ambulatory peritoneal dialysis (CAPD) variables on antibiotic activity.
Main Methods:
- Development of a standardized bacterial biofilm preparation of S. epidermidis.
- Evaluation of antibiotic activity using the developed biofilm assay.
- Testing of single and combination antibiotic therapies.
- Assessment of modulating effects of CAPD variables (dialysis fluid, PD solution additives) and antibiotic concentrations.
Main Results:
- The assay effectively measures the relative efficacy of various antibiotic treatments against S. epidermidis biofilms.
- Data on antibiotic effectiveness in single, double, and triple combinations are summarized.
- The impact of altered antibiotic concentrations and CAPD environmental factors on biofilm sterilization is quantified.
Conclusions:
- The developed assay provides a standardized method for evaluating antibiotic efficacy in biofilm infections.
- This research facilitates the logical planning of individualized therapeutic strategies for implant-associated infections.
- Optimizing antibiotic regimens through such assays can improve patient outcomes and device longevity.